RIL
HUMA icon

Rothschild Investment LLC’s Humacyte HUMA Stock Holding History

Rothschild Investment LLC’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56K Buy
1,999
+909
+83% +$842 ﹤0.01% 2859
2026
Q1 		$661 Buy
+1,090
New +$1.13K ﹤0.01% 3027
2025
Q3 		– Sell
-135
Closed -$282 – 3193
2025
Q2 		$282 Buy
135
+10
+8% +$19 ﹤0.01% 2870
2025
Q1 		$213 Buy
125
+60
+92% +$225 ﹤0.01% 2836
2024
Q4 		$328 Sell
65
-60
-48% -$297 ﹤0.01% 2666
2024
Q3 		$680 Buy
125
+60
+92% +$396 ﹤0.01% 2383
2024
Q2 		$312 Buy
+65
New +$338 ﹤0.01% 2276

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
LWM
LJI Wealth Management Indianapolis, Indiana $714M AUM 21.51% 1-Year Est. Return
UAS
United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return
EWM
Endowment Wealth Management Appleton, Wisconsin $259M AUM 15.06% 1-Year Est. Return

Rothschild Investment LLC's HUMA Position: Q2 2026 in Review

Rothschild Investment LLC increased its Humacyte (HUMA) stake by 83% in Q2 2026, buying an estimated $842 and bringing the position to 1,999 shares worth $1.56K. The position accounts for ﹤0.01% of the portfolio, ranked #2859.

Rothschild Investment LLC first reported a position in HUMA in Q2 2024 and has held it in 7 quarters since. 66 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Rothschild Investment LLC held 1,999 shares of Humacyte worth $1.56K as of Q2 2026.
  • Rothschild Investment LLC bought 909 Humacyte shares in Q2 2026, an estimated $842.
  • Humacyte made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2859 holding.
  • Rothschild Investment LLC first reported a position in Humacyte in Q2 2024 and has held it in 7 quarters since.
  • 66 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.